论文部分内容阅读
骁悉（Ｃｅｌｌｃｅｐｔ）是由瑞士罗氏（Ｒｌｃｈｅ）公司最新推出上市的新一代高效免疫抑制药，霉酚酸酯（Ｍｙｃｏｐｈｅｍｏｌａｔｅｍｏｆｅｔｉｌ，ＭＭＦ，ＲＳ－６１４４３）是其通用名。骁悉在肾脏移植临床应用方面获得成功，１９９６年通过美国食品与药物管理局（Ｆ
Cellcept is a new generation of high-potency immunosuppressant released by Roche Company in Switzerland. Mycophenolatemofetil (MMF, RS-61443) is its common name. Xiaoxitian kidney transplant clinical application of success, in 1996 through the United States Food and Drug Administration (F